Paige
National Institute for Health and Care Excellence Publishes Medtech Innovation Briefing on Paige Prostate
Paige, the global leader in AI-based diagnostic software in pathology, today announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) published a Medtech Innovation...
FDA Update: FDA Authorizes Software to Help Identify Prostate Cancer
Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for ...
Paige’s AI Diagnostic Tech Is Revolutionizing Cancer Diagnosis
The startup’s software analyzes tissue-sample imagesArtificial intelligence was not on Leo Grady‘s mind when he was applying for college in the early 1990s. The IEEE member was interested in human int...
Paige AI together with University of Oxford win Phase 4 Artificial Intelligence in Health and Care award from NHS Accelerated Access Collaborative
Thousands of patients and NHS staff will benefit from dozens of new pioneering projects awarded a share of £36 million to test state-of-the-art AI technology. Among the 38 projects awardees, Paige AI...
Quest Diagnostics and Paige Form Collaboration to Advance AI-generated Pathology Insights to Improve Cancer Diagnosis and Care
Goal to develop regulatory-approved software products and services based on AI-generated insights from Quest's digital pathology diagnostic data
Paige and Grupo Oncoclinicas Study Demonstrates Paige Prostate May Improve Pathology Workflow in Real-World Setting
Results from AI study showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment.
Paige and Leica Biosystems Partner to Expand Access to Computational Pathology Products for Pathology and Oncology Research
Paige, a global leader in AI-based digital diagnostics, and Leica Biosystems, a globally recognized cancer diagnostics and workflow solution leader, today announced a strategic partnership to expand a...
Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software
PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ — Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced ...
Paige Receives FDA Clearance for the FullFocus™ Viewer for Digital Pathology
Paige, a global leader in computational pathology, today announced it received Federal Drug Administration (FDA) 510(k) clearance for the FullFocus™, a digital pathology image viewer for the purpose o...